News: IMC Immuron Strategic Investment In Leading Gut Health Biotech Ateria Health

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Oct 13 (Reuters) - Immuron Ltd (IMC) :

    • IMMURON STRATEGIC INVESTMENT IN LEADING GUT HEALTH BIOTECH ATERIA HEALTH
    • IMMURON SAYS INTENTION TO ENTER INTO RECIPROCAL DISTRIBUTION AGREEMENT FOR TRAVELAN® IN U.K. MARKET AND JUVIA™ IN AUSTRALIAN AND NORTH AMERICAN MARKETS
    • UPFRONT CASH INVESTMENT OF £1.48M FUNDED FROM IMMURON'S EXISTING CASH RESERVES
    • NET PROCEEDS WILL BE USED BY ATERIA FOR PRODUCT LAUNCH AND ONGOING PRODUCT MARKETING OF JUVIA
    • NET PROCEEDS WILL BE USED BY ATERIA RESEARCH AND DEVELOPMENT (FURTHER CLINICAL TRIALS) FOR JUVIA PRODUCTS
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.0¢
Change
0.001(1.45%)
Mkt cap ! $18.77M
Open High Low Value Volume
6.8¢ 7.0¢ 6.8¢ $16.84K 244.6K

Buyers (Bids)

No. Vol. Price($)
1 10000 6.8¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 148417 1
View Market Depth
Last trade - 16.10pm 11/09/2025 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.